Eton Pharmaceuticals Inc (ETON) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Eton Pharmaceuticals, Inc. has announced the grant of a U.S. patent for its ET-400 oral liquid hydrocortisone formulation, with protection until 2043. This significant development is poised for inclusion in the FDA’s Orange Book following product approval, bolstering the company’s intellectual property portfolio as they await the decision on additional related patents.
For further insights into ETON stock, check out TipRanks’ Stock Analysis page.
